[1]
2025. Impact of Etelcalcetide on Cardiovascular Outcomes and Mortality in Hemodialysis Patients with Secondary Hyperparathyroidism: A Meta-Analysis. Open Access Indonesian Journal of Medical Reviews. 5, 1 (Mar. 2025), 41–54. DOI:https://doi.org/10.37275/oaijmr.v5i1.701.